Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3032641	u-aminoh	— (—)	79	99	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Care involving use of rehabilitation procedures

6.42

13.86

1.3

1.2

—

Metabolic disorders

6.21

11.70

1.7

1.1

—

Other disorders of amino-acid metabolism

+∞

11.59

2.3

0.0

—

Speech and linguistic disorders, excluding more controls

9.45

10.57

1.1

1.2

—

Mixed specific developmental disorders

6.74

9.27

1.0

1.3

—

Persons encountering health services for specific procedures and health care

4.08

9.27

1.3

1.2

—

Epilepsy

5.91

9.07

1.1

—

Urolithiasis

20.01

8.46

1.2

1.3

—

Mental retardation, excluding more controls

14.30

8.12

1.0

1.2

—

Renal tubulo-interstitial diseases

4.65

8.06

1.6

1.2

—

Convulsions, not elsewhere classified

6.98

7.86

1.2

—

Mental retardation

6.23

7.71

1.0

1.3

—

Mental retardation, wide definition

6.23

7.71

1.0

1.3

—

Disorders of psychological development

5.12

7.64

1.1

1.3

—

Chronic kidney disease

8.30

7.53

2.0

1.2

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

4.14

7.45

1.2

—

Hyperkinetic disorders, excluding more controls

8.12

7.33

1.1

1.2

—

Intestinal infectious diseases

3.52

6.90

1.3

1.2

—

Diarrhoea and gastroenteritis of presumed infectious origin

3.74

6.86

1.4

1.2

—

Fever of other and unknown origin

5.48

6.66

1.3

1.2

—

Speech and linguistic disorders

4.40

6.52

1.1

1.3

—

Other and unspecified mental retardation

6.76

6.32

1.0

1.4

—

Delayed milestone in childhood

4.45

6.03

1.0

1.3

—

Malaise and fatigue

6.11

6.00

1.4

1.2

—

Specific development disorders of speech and language

5.27

5.97

1.1

1.4

—

Renal failure

6.09

5.62

2.0

1.2

—

Nonsuppurative otitis media

4.17

5.21

1.4

1.2

—

Acute tubulo-interstitial nephritis

4.14

5.20

1.6

1.2

—

Psychiatric diseases

3.92

5.12

1.3

—

Any mental disorder

3.92

5.12

1.3

—

All influenza

5.27

5.03

1.6

1.1

—

Medical observation and evaluation for suspected diseases and conditions

4.78

4.97

1.1

1.2

—

Implicit Sepsis

4.21

4.74

1.2

1.1

—

Anxiety disorders, excluding more controls

5.21

4.73

1.2

1.3

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

3.38

4.67

1.1

1.2

—

Endocrine, nutritional and metabolic diseases

3.11

4.66

1.3

1.1

—

Disturbance of activity and attention

4.71

4.44

1.1

1.2

—

Codes for special purposes

4.07

4.15

1.4

1.3

—

Provisional assignment of new diseases of uncertain etiology

4.07

4.15

1.4

1.3

—

Implicit viral Sepsis

8.01

4.06

1.4

1.3

—

Viral Sepsis

8.01

4.06

1.4

1.3

—

Cerebral palsy

10.09

4.02

1.0

1.4

—

Anaemias

4.30

3.90

1.5

1.1

—

GASTRO-related operations

2.85

3.89

1.4

1.2

—

Any gastric operation

2.85

3.89

1.4

1.2

—

Cerebral palsy and other paralytic syndromes

7.28

3.85

1.0

1.4

—

Other functional intestinal disorders

3.25

3.85

1.1

1.2

—

Statin medication

6.23

3.81

1.8

1.2

—

Gastro-oesophageal reflux disease

4.22

3.80

1.1

—

Condition for Implicit Sepsis (Organ dysfunction codes)

3.39

3.80

1.2

1.1

—

Care involving dialysis

12.02

3.76

2.2

1.2

—

Unspecified haematuria

8.57

3.62

1.6

1.1

—

Astigmatism

6.16

3.49

1.0

1.3

—

Covid-19 confirmed case

6.16

3.49

1.3

1.4

—

Episodal and paroxysmal disorders

2.51

3.46

1.3

1.2

—

Other disorders starting during childhood or adolecense, excluding more controls

5.95

3.40

1.3

1.2

—

Procreative management

3.03

3.36

1.5

1.1

—

Dialysis, with operation codes

7.01

3.36

2.0

1.3

—

Transplanted organ and tissue status

5.72

3.34

1.5

1.1

—

Disorders of refraction and accommodation

3.43

3.31

1.1

1.2

—

Other and unspecified anaemias

6.77

3.28

1.6

1.2

—

Other anaemias

6.75

3.27

1.6

1.2

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

2.71

3.25

1.4

1.3

—

Symptoms and signs involving the urinary system

3.54

3.24

1.5

1.3

—

Aplastic and other anaemias

6.64

3.23

1.6

1.2

—

Neurological diseases

2.46

3.20

1.3

1.2

—

Other problems related to primary support group, including family circumstances

3.17

3.19

1.3

1.2

—

Specific development disorders of scholastic skills

6.31

3.16

1.0

1.4

—

Benzodiazepine use

3.28

3.12

1.2

1.5

—

Constipation

2.73

3.11

1.3

1.2

—

Other and unspecified tonsillitis

3.54

3.02

1.1

—

Diseases of oesophagus, stomach and duodenum

2.93

2.94

1.2

1.3

—

Acute upper respiratory infections of multiple and unspecified sites

2.95

2.92

1.3

—

Symptoms and signs involving the nervous and musculoskeletal systems

3.14

2.92

1.3

1.1

—

Motor disorders, excluding more controls

5.62

2.91

1.0

1.2

—

Kidney transplant status

6.68

2.87

1.7

1.2

—

Wide developmental disorders, excluding more controls

6.62

2.84

1.0

1.2

—

Viral and other specified intestinal infections

3.26

2.79

1.5

1.1

—

Influenza and pneumonia

2.31

2.77

1.5

1.2

—

Birth asphyxia

8.50

2.76

1.0

1.3

—

ILD medications: immunosuppressive drugs

2.88

2.75

1.6

1.2

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

2.40

2.73

1.3

—

Hyperkinetic disorders

3.19

2.71

1.1

1.3

—

Other disorders originating in the perinatal period

4.28

2.69

1.0

1.3

—

Specific developmental disorder of motor function

4.95

2.69

1.0

1.4

—

Implicit bacterial Sepsis

6.11

2.69

1.3

1.2

—

Hypertension, essential

5.71

2.67

1.7

1.3

—

Neurotic, stress-related and somatoform disorders

2.80

2.66

1.2

1.3

—

Anxiety disorders

2.79

2.64

1.2

1.3

—

Acute laryngitis and tracheitis

4.15

2.63

1.0

1.2

—

Disorders of other endocrine glands

2.67

2.63

1.4

1.2

—

Follow-up examination after treatment for conditions other than malignant neoplasms

6.55

2.61

1.2

1.5

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

2.76

2.58

1.3

1.2

—

Lack of expected normal physiological development

4.71

2.55

1.0

1.2

—

Congenital malformations of the nervous system

7.18

2.55

1.2

1.6

—

Melanocytic naevi

7.14

2.55

1.0

1.3

—

Abnormal serum enzyme levels

7.05

2.52

1.6

1.1

—

Abnormal findings on examination of blood, without diagnosis

4.37

2.44

1.9

1.2

—

Nephropathy related operations

5.00

2.40

2.2

1.2

—

Genitourinary diseases

2.27

2.39

1.2

1.1

—

Anxiety (asthma-related co-morbidities)

3.03

2.39

1.5

1.3

—

Hypoglycaemia, other or unspecified

6.26

2.37

1.0

1.4

—

Other disorders of glucose regulation and pancreatic internal secretion

6.26

2.37

1.0

1.4

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

3.64

2.36

1.4

1.1

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

2.21

2.35

1.3

1.2

—

Bacterial Sepsis

4.15

2.33

1.3

1.1

—

Headache

3.27

2.29

1.4

1.3

—

All influenza (not pneumonia)

4.62

2.27

1.7

1.1

—

L04AD Calcineurin inhibitors

3.89

2.25

1.6

1.1

—

Disorders of speech understanding and production

3.42

2.22

1.1

1.3

—

Melanocytic naevi

5.56

2.21

1.0

1.4

—

Glomerular diseases

4.29

2.15

1.0

1.4

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4.28

2.15

1.7

1.3

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4.27

2.14

1.7

1.1

—

Iron deficiency anaemia

4.24

2.13

1.3

1.4

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

4.28

2.12

2.0

1.2

—

Factors influencing health status and contact with health services

5.02

2.11

1.7

1.0

—

Nausea and vomiting

2.95

2.10

1.2

1.1

—

Viral infections characterized by skin and mucous membrane lesions

2.70

2.09

1.7

1.2

—

General examination and investigation of persons without complaint and reported diagnosis

3.19

2.08

1.3

1.2

—

Explicit Sepsis

3.20

2.08

1.3

1.2

—

Dental caries

2.88

2.04

1.6

1.2

—

Complications of medical and surgical care

3.50

2.04

1.9

1.3

—

Other reaction to severe stress, and adjustment disorders

4.00

2.04

1.5

1.2

—

Infections, IBD-co-morbidities

5.20

2.01

1.4

1.1

—

General symptoms and signs

2.51

2.01

1.2

1.3

—

Exclusions for E4_PCOS_BROAD

3.08

2.01

1.4

1.2

—

Disorders of skin appendages

3.08

2.01

1.3

1.2

—

Acute sinusitis

3.43

2.00

1.0

1.5

—

Other disorders of urethra and urinary system

3.15

1.98

1.6

1.4

—

All anxiety disorders

2.68

1.98

1.5

1.3

—

Examination and observation for other reasons

3.24

1.97

1.0

1.2

—

Focal epilepsy, strict definition

3.33

1.96

1.1

1.2

—

Focal epilepsy

3.33

1.96

1.1

1.2

—

Ischemic heart diseases

5.22

1.95

1.6

1.2

—

Bronchitis

2.37

1.95

1.4

1.3

—

Acute pharyngitis

3.31

1.95

1.1

—

Purpura and other haemorrhagic conditions

4.55

1.94

1.4

1.2

—

Acne

4.55

1.94

1.0

1.1

—

Diseases of the eye and adnexa

2.10

1.94

1.1

1.3

—

Pervasive developmental disorders excl. Autism + Asperger

4.56

1.94

1.0

1.6

—

Persons encountering health services for examination and investigation

3.01

1.94

1.4

1.2

—

Nutritional anaemias

3.65

1.88

1.3

—

Persons encountering health services in other circumstances, wide

2.01

1.88

1.3

1.2

—

Irregular menses

4.51

1.87

1.8

—

Other viral diseases

2.39

1.84

1.2

—

Contraceptive management

4.39

1.79

1.2

1.0

—

Deposits [accretions] on teeth

2.76

1.78

1.5

1.2

—

Other strabismus

2.75

1.78

1.0

1.3

—

Excessive, frequent and irregular menstruation

4.64

1.77

1.2

1.5

—

Otitis media, unspecified

2.73

1.75

1.1

1.2

—

Polycystic ovarian syndrome, consortium definition

3.62

1.73

1.7

—

Autoimmune diseases excluding thyroid diseases, strict definition

2.02

1.73

1.4

1.2

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

3.76

1.72

1.5

1.3

—

Persons encountering health services in circumstances related to reproduction

2.07

1.72

1.3

1.1

—

Coagulation defects, purpura and other haemorrhagic conditions

3.85

1.71

1.4

1.2

—

Other and unspecified iron deficiency

3.85

1.71

1.4

—

Dentinal caries

2.90

1.71

1.3

—

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

2.63

1.69

1.3

1.2

—

Used for control exclusion in common control thyroid runs

1.93

1.68

1.3

1.2

—

Motor disorders

2.81

1.64

1.0

1.2

—

Autoimmune diseases excluding thyroid diseases

1.97

1.63

1.4

1.2

—

Second line medication for Crohn's disease

2.50

1.59

1.4

1.3

—

Strabismus

2.50

1.59

1.0

1.3

—

Hypopituitarism

3.00

1.58

1.5

1.2

—

Acute suppurative otitis media

2.49

1.57

1.3

1.2

—

Fracture of lower leg, including ankle

2.99

1.57

1.5

1.1

—

Acute upper respiratory infections

2.21

1.57

1.2

1.3

—

Pneumonia, organism unspecified

2.02

1.54

1.6

1.2

—

Hypertensive diseases (excluding secondary)

2.62

1.53

1.7

1.4

—

Wide developmental disorders

2.86

1.50

1.0

1.4

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1.91

1.50

1.5

1.2

—

Septicaemia

2.59

1.50

1.3

1.2

—

Suppurative and unspecified otitis media

2.49

1.49

1.2

—

Complications of procedures, not elsewhere classified

2.88

1.49

1.7

1.3

—

Osteopathies and chondropathies

2.84

1.49

1.5

1.3

—

Pneumonias (Asthma/COPD co-morbidities)

1.88

1.45

1.5

1.2

—

Dental caries 2 and operation codes

2.07

1.44

1.6

1.2

—

Other endocrine disorders

2.28

1.41

1.4

1.2

—

Dental caries 2

2.05

1.40

1.6

1.2

—

Other viral diseases, not elsewhere classified

2.25

1.39

1.0

1.2

—

Hypertension

2.31

1.39

1.7

1.3

—

Symptoms and signs involving the digestive system and abdomen

1.85

1.38

1.3

1.2

—

Other special examinations and investigations of persons without complaint or reported diagnosis

2.70

1.38

1.3

1.2

—

All pneumoniae

1.84

1.37

1.5

1.2

—

Other neurological diseases

2.68

1.37

1.3

—

Dyspnoea

2.22

1.36

1.3

1.2

—

Congenital malformations of the circulatory system

2.15

1.36

1.3

1.2

—

Migraine without aura

2.94

1.36

1.4

1.1

—

2.24

1.35

1.7

1.3

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

2.24

1.35

1.7

1.3

—

Hypertensive diseases

2.21

1.33

1.7

1.3

—

Pain in throat and chest

2.20

1.33

1.3

—

Complications of surgical and medical care, not elsewhere classified

2.49

1.33

1.8

1.3

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

2.10

1.29

1.1

1.2

—

Mood disorders, excluding more controls

2.61

1.28

1.3

—

Bleeding

2.33

1.27

1.3

1.2

—

Other septicaemia

2.45

1.27

1.3

1.2

—

Short stature, not elsewhere classified

2.28

1.26

1.5

1.2

—

Other symptoms and signs involving the nervous and musculoskeletal systems

2.40

1.24

1.3

1.2

—

Autoimmune diseases related-to ILD

2.20

1.22

1.5

1.3

—

Other disorders starting during childhood or adolescence

2.15

1.20

1.3

1.2

—

Certain infectious and parasitic diseases

1.83

1.20

1.3

1.2

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

2.16

1.19

1.3

1.4

—

Other antidepressants

2.20

1.18

1.3

1.6

—

Depression medications

2.80

1.17

1.4

1.0

—

Cardiac murmurs and other cardiac sounds

2.28

1.17

1.2

—

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

0.00

1.16

0.0

1.2

—

Superficial injury of head

2.50

1.15

1.0

1.3

—

Congenital malformations, deformations and chromosomal abnormalities

2.00

1.15

1.5

1.3

—

Transitory endocrine and metabolic disorders specific to fetus and newborn

0.00

1.15

0.0

1.2

—

Other diseases of hard tissues of teeth

1.95

1.14

1.4

1.2

—

Concussion

2.04

1.13

1.3

1.2

—

Open wound of head

2.02

1.13

1.3

1.2

—

Diseases of the ear and mastoid process

1.88

1.12

1.5

1.3

—

Visual disturbances and blindness

2.33

1.12

1.1

1.2

—

L04AX Other immunosuppressants

2.33

1.12

1.4

1.2

—

Dentofacial anomalies [including malocclusion]

2.23

1.09

1.0

1.2

—

Temporomandibular joint disorders, including avohilmo

2.38

1.09

1.0

1.5

—

Noninflammatory disorders of female genital tract

2.52

1.05

1.2

1.4

—

Diseases of middle ear and mastoid

1.99

1.04

1.4

1.2

—

Autoimmune diseases

1.67

1.04

1.2

—

Other acute lower respiratory infections

1.91

1.03

1.2

—

Pain in joint

2.11

1.03

1.0

1.2

—

Migraine

2.05

1.02

1.4

1.2

—

Acute appendicitis

2.25

1.01

1.0

1.7

—

Disorders of eyelid, lacrimal system and orbit

2.03

1.00

1.1

1.3

—

Use of hypnotics and sedatives

1.86

0.98

1.3

1.4

—

Injuries to the shoulder and upper arm

1.89

0.93

1.4

1.2

—

Persons encountering health services in other circumstances

2.14

0.91

1.3

1.2

—

Personal history of other diseases and conditions

2.13

0.91

1.5

1.2

—

Dental operations

1.96

0.90

1.6

1.1

—

Acute bronchitis

2.10

0.90

1.0

1.3

—

1.82

0.89

1.3

—

Tooth eruption problems

2.05

0.88

1.0

1.2

—

Symptoms and signs involving the circulatory and respiratory systems

1.63

0.87

1.3

—

Exposure to unspecified factor

1.63

0.82

1.4

1.2

—

Depression

1.72

0.80

1.3

1.4

—

Dental caries 2, only avohilmo

1.75

0.80

1.7

1.2

—

Intracranial trauma

1.71

0.80

1.3

1.2

—

Neurological diseases, wide definition

1.81

0.79

1.3

1.2

—

ILD medications

1.60

0.78

1.5

1.2

—

COPD/asthma related infections

1.79

0.78

1.3

—

COPD/asthma/ILD related infections

1.79

0.78

1.3

—

Other arrhythmias

2.25

0.77

1.4

1.2

—

Congenital malformations of heart and great arteries

1.65

0.77

1.1

1.2

—

Asthma, unspecified (mode)

2.20

0.76

1.0

1.2

—

Asthma, unspecified (mode), excluding more controls

2.18

0.76

1.0

1.2

—

Appendicitis, broad definition

2.18

0.76

1.0

1.7

—

Diseases of appendix

2.17

0.76

1.0

1.7

—

Heart failure, not strict

2.15

0.76

1.4

1.2

—

Exposure to other specified factors

1.65

0.74

1.2

1.3

—

Asthma (only as main-diagnosis)

1.84

0.74

1.3

1.2

—

Asthma (only as main-diagnosis), excluding more controls

1.81

0.73

1.3

1.2

—

1.62

0.73

1.1

1.2

—

Depression or dysthymia

2.00

0.71

1.6

1.3

—

Conjunctivitis (acute, non atopic)

1.74

0.71

1.7

1.1

—

Unspecified fall

1.74

0.70

1.4

1.1

—

Mouth breathing

1.71

0.69

1.3

1.2

—

Disorders of tooth development and eruption

1.87

0.69

1.0

1.2

—

Parasetamol

1.70

0.69

1.3

1.4

—

Asthma-related infections

1.53

0.68

1.1

1.2

—

Asthma, hospital admission 2, infections

1.53

0.68

1.1

1.2

—

Asthma (mode)

1.67

0.67

1.3

1.2

—

Congenital malformations of cardiac septa

1.65

0.67

1.1

1.2

—

Malignant neoplasm, wide definition for exclusion

1.65

0.67

1.7

1.3

—

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

1.65

0.67

1.7

1.3

—

Abnormalities of breathing

1.58

0.67

1.3

—

Anomalies of dental arch relationship, including avohilmo

1.61

0.66

1.3

1.2

—

Diseases of the musculoskeletal system and connective tissue

0.57

0.65

1.8

1.2

—

Any reimbursement code in KELA

1.67

0.64

1.3

1.0

—

Mood [affective] disorders

1.64

0.63

1.3

1.4

—

Mood disorders

1.64

0.62

1.3

1.4

—

ILD medications: prednisolone, methylprednisolone, prednisone

1.59

0.62

1.4

1.2

—

Other specific joint derangements/joint disorders

1.63

0.62

1.3

—

Infections of the skin and subcutaneous tissue

1.63

0.61

1.0

1.2

—

Other fall from one level to another

1.67

0.61

1.2

1.3

—

Other diseases of upper respiratory tract

0.61

1.6

1.2

—

Allergic colitis

0.00

0.60

0.0

1.2

—

Accidents

0.56

0.59

1.8

1.2

—

Other external causes of accidental injury

0.56

0.59

1.8

1.2

—

Other diseases of intestines

1.43

0.55

1.3

—

Other diseases of urinary system

1.49

0.54

1.2

—

Cardiac arrhythmias

1.59

0.54

1.3

1.1

—

Asthma

1.63

0.51

1.3

1.2

—

Asthma, excluding more controls

1.62

0.51

1.3

1.2

—

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

1.53

0.49

1.7

1.3

—

Acute bronchiolitis

1.54

0.48

1.0

1.2

—

Dental pulpitis 2

0.58

0.48

1.6

1.2

—

Dental pulpitis 2, only avohilmo

0.58

0.48

1.6

1.2

—

Dental caries, including avohilmo

0.58

0.48

1.6

1.2

—

Dental caries 1

0.58

0.48

1.6

1.2

—

Other disorders of ear

1.46

0.47

1.1

1.3

—

Dental pulpitis 3

1.44

0.46

1.0

1.1

—

Intracranial injury

1.41

0.45

1.0

1.2

—

Delivery

0.00

0.43

0.0

1.4

—

Delivery, wide proxy

0.00

0.43

0.0

1.4

—

Pregnancy, childbirth and the puerperium

0.00

0.43

0.0

1.4

—

Medical abortion

0.00

0.43

0.0

1.9

—

Complications of labour and delivery

0.00

0.43

0.0

1.7

—

Urticaria

1.61

0.43

1.0

1.3

—

Other bacterial diseases

1.42

0.42

1.3

1.2

—

Pregnancy with abortive outcome

0.00

0.42

0.0

1.8

—

Insulin, combination of fast acting with intermediate-acting or long-acting

1.54

0.41

1.6

1.2

—

Diabetes, varying definitions

1.37

0.41

1.6

1.3

—

Other nutritional deficiencies

1.53

0.41

1.4

—

Diabetes mellitus

1.36

0.41

1.6

1.3

—

Fetus and newborn affected by maternal complications of pregnancy

0.00

0.41

0.0

1.2

—

Infections specific to the perinatal period

0.00

0.41

0.0

1.1

—

Asthma and allergy

0.00

0.41

0.0

1.1

—

Asthma and allergy, excluding more controls

0.00

0.41

0.0

1.1

—

Coeliac disease

0.00

0.41

0.0

1.3

—

Superficial injury of ankle and foot

0.00

0.41

0.0

1.3

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

0.00

0.41

0.0

1.3

—

Pedal cyclist injured in transport accident

0.00

0.41

0.0

1.3

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

0.00

0.40

0.0

1.2

—

Urticaria and erythema

1.47

0.40

1.0

1.2

—

Left ventricular outflow tract obstruction, narrow definition

0.00

0.40

0.0

1.3

—

Allergic asthma (mode)

0.00

0.39

0.0

1.1

—

Allergic asthma (mode), excluding more controls

0.00

0.39

0.0

1.1

—

Insulin medication

1.42

0.39

1.6

1.2

—

Adverse effects, not elsewhere classified

0.00

0.39

0.0

1.4

—

Inflammatory bowel disease treatment related agents

1.39

0.37

1.5

1.3

—

Noninfective enteritis and colitis

1.35

0.37

1.6

1.2

—

Malignant neoplasm

1.48

0.37

1.8

1.3

—

Any event in cancer register

1.48

0.37

1.8

1.4

—

Diseases of the skin and subcutaneous tissue

1.37

0.36

1.2

—

Conjunctivitis

1.26

0.36

1.6

1.2

—

Cardiovascular diseases

1.34

0.35

1.3

1.2

—

Diseases of the respiratory system

1.37

0.35

1.5

1.2

—

Dental pulpitis 3, only avohilmo

1.37

0.34

1.0

1.2

—

Dental caries 1 and operation codes

0.68

0.34

1.7

1.2

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

1.35

0.34

1.0

1.4

—

Triptan medication for migraine, single purchase ok

1.35

0.34

1.0

1.4

—

Asthma/COPD (KELA code 203)

0.69

0.33

1.2

—

Abdominal and pelvic pain

1.34

0.33

1.2

—

Disorders of the thyroid gland

1.31

0.33

1.5

1.4

—

Disorders of conjunctiva

1.35

0.31

1.7

1.2

—

Contact with and exposure to communicable diseases

1.32

0.30

1.0

1.2

—

Dental caries 2 and operation codes, only avohilmo

1.31

0.28

1.5

1.3

—

Asthma, including avohilmo

0.76

0.28

1.3

1.2

—

Gastrointestinal diseases

1.32

0.25

1.3

1.1

—

External causes of morbidity and mortality

0.73

0.25

1.7

1.2

—

Asthma, hospital admissions , main diagnosis only

1.20

0.25

1.3

1.2

—

Hypothyroidism, other/unspecified

1.27

0.23

1.6

1.5

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

1.27

0.23

1.6

1.5

—

Deep bite

1.25

0.22

1.2

—

Gonarthrosis [arthrosis of knee](FG)

0.00

0.22

0.0

1.7

—

Soft tissue disorders

0.77

0.22

1.3

—

Single spontaneous delivery

0.00

0.22

0.0

1.6

—

Heart failure,strict

0.00

0.22

0.0

1.4

—

Other abnormal products of conception

0.00

0.22

0.0

2.0

—

Diseases of arteries, arterioles and capillaries

0.00

0.21

0.0

1.4

—

Cholecystectomy

0.00

0.21

0.0

1.8

—

All-cause Heart Failure

0.00

0.21

0.0

1.3

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

0.00

0.21

0.0

1.5

—

Cholelithiasis

0.00

0.21

0.0

1.8

—

Disorders of puberty, all

0.00

0.21

0.0

1.3

—

Generalized epilepsy

0.00

0.21

0.0

1.4

—

Contact with heat and hot substances

0.00

0.21

0.0

1.3

—

Hernia of abdominal wall

0.00

0.21

0.0

1.4

—

Other pulmonary diagnosis

1.31

0.21

1.5

1.2

—

Excluding asthma or asthma-COPD overlap

1.31

0.21

1.5

1.2

—

COPD differential diagnosis

1.31

0.21

1.5

1.2

—

ILD differential diagnosis

1.31

0.21

1.5

1.2

—

Chronic suppurative otitis media, including avohilmo

0.00

0.21

0.0

1.5

—

Septal defects

1.16

0.21

1.2

—

Heart failure, strict

0.00

0.21

0.0

1.3

—

Selective serotonin reuptake inhibitors

1.26

0.21

1.0

1.5

—

Cystitis

1.26

0.20

1.3

—

Cholelithiasis, broad definition with cholecystitis

0.00

0.20

0.0

1.7

—

Burns and corrosions of external body surface, specified by site

0.00

0.20

0.0

1.4

—

Burns and corrosions

0.00

0.20

0.0

1.4

—

Finngen Rheumatological endpoints

1.18

0.19

1.2

1.5

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1.18

0.19

1.8

1.2

—

Fall on same level

1.21

0.19

1.5

1.2

—

Persons with potential health hazards related to communicable diseases

1.20

0.18

1.0

1.2

—

Exclusions for E4_PCOS_CONSORTIUM

1.15

0.18

1.7

1.3

—

Injuries to the wrist and hand

0.72

0.17

1.6

1.3

—

Atopic dermatitis

0.74

0.17

2.0

1.2

—

Other joint disorders

1.15

0.17

1.1

1.3

—

Other soft tissue disorders, not elsewhere classified

1.16

0.15

1.0

1.4

—

Injuries to the knee and lower leg

1.12

0.15

1.4

1.2

—

Cardiovascular diseases (excluding rheumatic etc)

1.18

0.12

1.6

1.2

—

First line medication for Crohn's disease

1.18

0.12

1.4

1.2

—

Injuries to the head

1.16

0.10

1.0

1.3

—

Hernia

1.09

0.10

1.4

1.2

—

Oral corticosteroids

1.04

0.09

2.2

1.4

—

Diabetes, insulin treatment (Kela reimbursement)

1.11

0.09

1.8

1.2

—

Atopic dermatitis, strict definition

1.05

0.08

2.2

1.1

—

Falls/tendency to fall

1.12

0.08

1.3

1.2

—

Benign neoplasms

1.10

0.08

1.4

1.3

—

Injury, poisoning and certain other consequences of external causes

0.79

0.08

1.7

1.2

—

Dorsopathies

1.05

0.07

1.3

—

Dental pulpitis 4, only avohilmo

1.04

0.07

1.0

1.3

—

Antihypertensive medication - note that there are other indications

1.04

0.07

1.5

1.1

—

Chronic diseases of tonsils and adenoids

1.04

0.07

1.4

1.2

—

Tonsillectomy and adenotomy

0.86

0.07

1.4

1.3

—

Chronic lower respiratory diseases

0.90

0.06

1.5

1.2

—

Neoplasms

0.97

0.00

1.5

1.2

—

Other dorsopathies, not elsewhere classified

0.94

0.00

1.4

—

Other eating disorders

0.00

0.0

1.5

—

Hydrocephalus

0.00

0.0

1.4

—

Schizophrenia, schizotypal and delusional disorders

0.00

0.0

1.4

—

Cystic kidney disease

0.00

0.0

1.6

—

Coronary revascularization (ANGIO or CABG)

0.00

0.0

1.2

—

Eustachian salpingitis and obstruction

0.00

0.0

1.4

—

Prolonged pregnancy

0.00

0.0

1.8

—

Pneumonia derived septicemia

0.00

0.0

1.4

—

Subjective visual disturbances

0.00

0.0

1.5

—

Effects of other external causes

0.00

0.0

1.6

—

Superficial injury of thorax

0.00

0.0

1.7

—

Long labour

0.00

0.0

2.0

—

Injury of unspecified body region

0.00

0.0

1.5

—

Antenatal screening

0.00

0.0

1.0

—

Schizophrenia or delusion

0.00

0.0

1.4

—

Eating disorder

0.00

0.0

1.5

—

Other and unspecified injuries of head

0.00

0.0

1.6

—

Benign neoplasms

1.00

0.00

1.4

—

Chronic suppurative otitis media

0.00

0.0

1.6

—

Umbilical hernia

0.00

0.0

1.1

—

Ocular pain

0.00

0.0

1.7

—

Pediculosis, acariasis and other infestations

0.00

0.0

1.6

—

Phobic anxiety disorders

0.00

0.0

1.2

—

Injuries to the neck

0.00

0.0

1.5

—

Other and unspecified nonorganic psychotic disorders

0.00

0.0

1.4

—

Torsion of testis

0.00

0.0

1.3

—

Gingivitis and periodontal diseases

1.00

0.00

1.3

1.2

—

Superficial injury of hip and thigh

0.00

0.0

1.6

—

Injury of eye and orbit

0.00

0.0

1.3

—

Other cataract

0.00

0.0

1.6

—

Foreign body entering into or through eye or natural orifice

0.00

0.0

1.5

—

Congenital musculoskeletal deformities of head, face, spine and chest

0.00

0.0

1.5

—

Disorders of vitreous body and globe

0.00

0.0

1.4

—

Open wound of ankle and foot

0.00

0.0

1.2

—

Pain in limb

0.94

0.00

1.0

1.3

—

Chondropathies

0.00

0.0

1.5

—

0.00

0.0

1.1

—

Burn and corrosion of wrist and hand

0.00

0.0

1.7

—

Contact with other sharp object(s)

0.00

0.0

1.6

—

Pedal cyclist injured in other and unspecified transport accidents

0.00

0.0

1.4

—

Desensitization to allergens

0.00

0.0

1.3

—

Pedal cyclist injured in noncollision transport accidents

0.00

0.0

1.4

—

Motorcycle rider injured in other and unspecified transport accidents

0.00

0.0

1.6

—

Car occupant injured in other and unspecified transport accidents

0.00

0.0

1.6

—

Bitten or struck by other mammals

0.00

0.0

1.5

—

Overexertion and strenuous or repetitive movements

0.00

0.0

1.6

—

Caught, crushed, jammed or pinched in or between objects

0.00

0.0

1.5

—

Contact with other hot fluids

0.00

0.0

1.3

—

Acute lymphadenitis

0.00

0.0

1.5

—

Scabies

0.00

0.0

1.6

—

Injuries to unspecified part of trunk, limb or body region

0.00

0.0

1.6

—

Contusion of other and unspecified parts of foot

0.00

0.0

1.4

—

Foreign body in respiratory tract

0.00

0.0

1.5

—

Stomatitis and related lesions

0.00

0.0

1.3

—

Pneumococcal septicemia

0.00

0.0

1.4

—

Dislocation, sprain and strain of joints and ligaments at neck level

0.00

0.0

1.8

—

Single delivery by forceps and vacuum extractor

0.00

0.0

1.8

—

Voice disturbances

0.00

0.0

1.6

—

Other symptoms and signs involving the digestive system and abdomen

0.00

0.0

1.4

—

Rash and other nonspecific skin eruption

0.00

0.0

1.3

—

Heartburn

0.00

0.0

1.4

—

Glaucoma

0.00

0.0

1.6

—

Gonarthrosis

0.00

0.0

1.8

—

Congenital malformations of aortic and mitral valves

0.00

0.0

1.1

—

Congenital deformities of feet

0.00

0.0

1.4

—

Slow fetal growth and fetal malnutrition

0.00

0.0

1.4

—

Fenamates

0.00

0.0

2.2

—

Adalimumab

0.00

0.0

1.8

—

Other infections specific to the perinatal period

0.00

0.0

1.2

—

Birth trauma

0.00

0.0

1.6

—

Fetus and newborn affected by maternal conditions that may be unrelated to present pregnancy

0.00

0.0

1.4

—

Tumor necrosis factor alpha inhibitors

0.00

0.0

1.6

—

Carpal tunnel syndrome

0.00

0.0

1.7

—

Perforation of tympanic membrane

0.00

0.0

1.3

—

Otitis externa, unspecified

0.00

0.0

1.4

—

Other heart diseases

0.97

0.00

1.8

1.2

—

Obstructed labour due to malposition and malpresentation of fetus

0.00

0.0

2.0

—

Arthropathies

0.93

0.00

1.1

1.3

—

Oxicams

0.00

0.0

2.0

—

Dental pulpitis 1, only avohilmo

0.89

0.00

1.0

1.3

—

Osteomyelitis

0.00

0.0

1.4

—

Behavioural disorders

0.00

0.0

1.6

—

Substance use, excluding alcohol

0.00

0.0

1.6

—

Dental pulpitis 4

0.94

0.00

1.0

1.3

—

Dental pulpitis 1

0.94

0.00

1.0

1.3

—

Mesial bite

0.00

0.0

1.6

—

Perineal laceration during delivery

0.00

0.0

1.7

—

Exclusion endpoint for supernumerary teeth

0.00

0.0

1.5

—

Diseases of oral cavity, salivary glands and jaws

0.92

0.00

1.4

1.2

—

Diseases of pulp and periapical tissues, including avohilmo

0.94

0.00

1.0

1.3

—

Varicose veins

0.00

0.0

1.4

—

Dental operations, only avohilmo

0.91

0.00

1.6

1.2

—

Asthma (diagnoses ohter than nonallergic)

0.89

0.00

1.1

1.3

—

Other chronic obstructive pulmonary disease, including avohilmo

0.00

0.0

1.4

—

Emergency coronary revascularization (for ACS)

0.00

0.0

1.5

—

Other disorders of teeth and supporting structures

0.00

0.0

1.4

—

Pain (limb, back, neck, head abdominally)

0.93

0.00

1.3

1.2

—

Other heart diseases, wide

0.95

0.00

1.6

1.2

—

Peritonsillar abscess

0.00

0.0

1.0

—

Irritable bowel syndrome

0.00

0.0

1.6

—

Atopic conjunctivitis

0.00

0.0

1.4

—

Aortic valve malfunction, age under 60 years

0.00

0.0

1.4

—

Social phobias

0.00

0.0

1.4

—

Non-ischemic cardiomyopathy

0.00

0.0

1.1

—

Diseases of male genital organs

0.96

0.00

1.0

1.2

—

Insomnia

0.00

0.0

1.5

—

Eating disorders

0.00

0.0

1.5

—

Heart failure and antihypertensive medication

0.00

0.0

1.2

—

Childhood allergy (age < 16)

0.95

0.00

1.7

1.1

—

Infectious mononucleosis

0.00

0.0

1.2

—

Diabetes medication

0.87

0.00

1.6

1.3

—

Dermatitis and eczema

0.98

0.00

1.7

1.2

—

Haemangioma and lymphangioma, any site

0.00

0.0

1.6

—

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

0.00

0.0

1.6

—

Bacterial sepsis of newborn

0.00

0.0

1.2

—

Injuries to the ankle and foot

0.84

0.00

1.4

1.3

—

Atopic dermatitis, strict definition with reimbursement

0.95

0.00

2.4

1.2

—

Mandibular prognathia

0.00

0.0

1.3

—

Mandibular prognathia AND surgery (LeFortI or BSSO or LeFortI AND BSSO), including avohilmo

0.00

0.0

1.3

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Amino acids panel - Urine

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS